Skip to main content

Table 1 Characteristics for the 54 patients entered into the study

From: Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanoma

Parameter VCML treated (n = 54)
Age (Yrs)   
Mean 61.6  
Median 66  
Range 35-97  
<55 18  
55- < 65 14  
65+ 22  
Gender   
Male 32  
Female 22  
Performance status   
  ECOG UICC
  0 = 51 0 = 51
  1 = 2 1 = 2
  2 = 1 2 = 1
M classification   
IIIb 1 (2%)  
IIIc 5 (9%)  
M1a 6 (11%)  
M1b 14 (26%)  
M1c 28 (52%)